Learn more about Peter Attia’s digital program
A hidden blockbuster drug for Alzheimer’s disease?
How, you might ask, can a company withhold information about a drug that could potentially prevent such a devastating disease?
#120 – AMA with Dom D’Agostino, Ph.D., Part II of II: Ketosis for cancer and chronic disease, hyperbaric oxygen therapy, and the effect of ketosis on female health
“The function of the mitochondria and mitochondrial health are the ultimate mitigator of neurodegenerative diseases…just by reducing the potential for reactive oxygen species related damage.” — Dom D’Agostino
#123 – Joan Mannick, M.D. & Nir Barzilai, M.D.: Rapamycin and metformin—longevity, immune enhancement, and COVID-19
“I think what the mTOR inhibitors are doing is not stopping people from getting infected [with a virus], but if you get infected, there’s a better immune response and your symptoms will be milder.” — Joan Mannick
#132 – AMA #16: Exploring hot and cold therapy
“All of the work that went into this analysis earlier in the year, it really changed my tune. And I think I’m now at the point where I kind of want to have a sauna, frankly, in the tool kit for longevity.” — Peter Attia
#161 – AMA #23: All Things Nicotine: deep dive into its cognitive and physical benefits, risks, and mechanisms of action
“It’s so fascinating to me frankly that one molecule found in nature can be so potent. It’s hard to imagine you could engineer a drug to do this.” —Peter Attia
#166 – Patricia Corby, D.D.S.: Importance of oral health, best hygiene practices, and the relationship between poor oral health and systemic disease
“You can maintain optimal oral health just by brushing teeth, by flossing really well, and having good nutrition.” —Pat Corby
A radical new approach to Alzheimer’s?
Perhaps a bigger takeaway from this article is the approach this particular group takes: a consortium from different fields converging on the problem is likely the right way to address a problem as daunting as Alzheimer’s disease.
Alzheimer’s disease and glucose metabolism
“In Alzheimer’s Research, Glucose Metabolism Moves to Center Stage.”
Studying Studies: Part I – relative risk vs. absolute risk
Reporting relative risk values alone can be inappropriate and misleading for the individual and the public.
Living with Alzheimer’s
North is to south what the clock is to time
There’s east and there’s west and there’s everywhere life
I know I was born and I know that I’ll die
The in between is mine
I am mine
– Pearl Jam